Hemophilia Liver Transplantation Observational Study
Autor: | Michael T. Wong, Bijan Eghtesad, Kenneth E. Sherman, Emily A. Blumberg, Peter G. Stock, Margaret V. Ragni, Valentina Stosor, Burc Barin, Donald Stablein, John J. Fung, Abhinav Humar, Nicholas N. Nissen |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
CD4-Positive T-Lymphocytes Male medicine.medical_specialty Time Factors medicine.medical_treatment Hepatitis C virus HIV Infections 030204 cardiovascular system & hematology Liver transplantation medicine.disease_cause Hemophilia A Gastroenterology 03 medical and health sciences Liver disease 0302 clinical medicine Postoperative Complications Internal medicine medicine Odds Ratio Humans Registries Retrospective Studies Transplantation Univariate analysis Hepatology business.industry Coinfection Hazard ratio virus diseases Odds ratio Hepatitis C Chronic Middle Aged medicine.disease United States Liver Transplantation Treatment Outcome Anti-Retroviral Agents Data Interpretation Statistical Multivariate Analysis Disease Progression 030211 gastroenterology & hepatology Surgery Female business Liver Failure |
Zdroj: | Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 23(6) |
ISSN: | 1527-6473 |
Popis: | Hepatitis C virus (HCV) infection is the leading cause of liver disease in hemophilia patients. In those with human immunodeficiency virus (HIV)/HCV coinfection, the rate of liver disease progression is greater than in HCV monoinfected individuals. Despite antiretroviral therapy, which slows HCV liver disease progression, some require transplantation. Whether transplant outcomes are worse in hemophilic (H) rather than nonhemophilic (NH) candidates is unknown. In order to determine rates and predictors of pretransplant and posttransplant survival, we conducted a retrospective observational study using United Network for Organ Sharing national transplant registry data, comparing HCV+ H and NH candidates. We identified 2502 HCV+ liver transplant candidates from 8 US university-based transplant centers, between January 1, 2004 to December 31, 2010, including 144 HIV+ (6%) and 2358 HIV–; 36 H (1%) and 2466 NH; 1213 (48%) transplanted and 1289 not transplanted. Other than male predominance and younger age, each were P |
Databáze: | OpenAIRE |
Externí odkaz: |